Coherus BioSciences
CHRS
#10164
Rank
ยฃ43.68 M
Marketcap
ยฃ0.28
Share price
-4.47%
Change (1 day)
-71.08%
Change (1 year)

Coherus BioSciences (CHRS) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : ยฃ99.63 Million

According to Coherus BioSciences 's latest financial reports the company's total liabilities are ยฃ99.63 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Coherus BioSciences - Total liabilities on balance sheet (from 2013 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31ยฃ0.14 B-68.33%
2024-12-31ยฃ0.46 B-28.39%
2023-12-31ยฃ0.64 B26.41%
2022-12-31ยฃ0.51 B18.61%
2021-12-31ยฃ0.43 B4.75%
2020-12-31ยฃ0.41 B77.6%
2019-12-31ยฃ0.23 B112.95%
2018-12-31ยฃ0.10 B11.29%
2017-12-31ยฃ97.72 M-24.22%
2016-12-31ยฃ0.12 B-12.86%
2015-12-31ยฃ0.14 B91.27%
2014-12-31ยฃ77.37 M42.08%
2013-12-31ยฃ54.45 M407.58%
2012-12-31ยฃ10.72 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
ยฃ64.17 B 64,306.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
ยฃ0.64 B 543.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
ยฃ0.20 B 105.11%๐Ÿ‡บ๐Ÿ‡ธ USA